Medicover AB
STO:MCOV B

Watchlist Manager
Medicover AB Logo
Medicover AB
STO:MCOV B
Watchlist
Price: 207.5 SEK -1.19% Market Closed
Market Cap: kr31.2B

Medicover AB
Other Long-Term Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Medicover AB
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Medicover AB
STO:MCOV B
Other Long-Term Assets
€45.4m
CAGR 3-Years
42%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Dedicare AB (publ)
STO:DEDI
Other Long-Term Assets
kr15.9m
CAGR 3-Years
245%
CAGR 5-Years
61%
CAGR 10-Years
45%
NGS Group AB
STO:NGS
Other Long-Term Assets
kr10.8m
CAGR 3-Years
90%
CAGR 5-Years
57%
CAGR 10-Years
13%
I
INIFY Laboratories AB
OSE:INIFY
Other Long-Term Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medicover AB
Glance View

Market Cap
31.2B SEK
Industry
Health Care

Medicover AB, founded in 1995, is a prominent healthcare and diagnostic service provider, chiefly operating across Europe and India. The company, based out of Sweden, has carved a niche by offering a broad range of healthcare services, focusing on accessible and premium quality care. Medicover’s structure is multifaceted—comprising two main divisions: Healthcare Services and Diagnostic Services. Their healthcare division administers preventative and primary care services through outpatient clinics, as well as specialist hospital care, emphasizing a holistic approach to patient care. Meanwhile, the Diagnostic Services division performs a vital role, supplying an extensive array of laboratory and imaging services. This dual-pronged business model ensures a steady stream of revenue, bolstering Medicover’s position in the competitive healthcare landscape. The way Medicover makes money is intricately tied to its wide-reaching network and comprehensive service offerings. Revenues are primarily derived from the fees for healthcare and diagnostic services provided directly to patients and through contracts with insurance companies and corporate clients, who seek Medicover’s expertise in employee health management. In navigating the healthcare sector, Medicover leverages its robust technological infrastructure to optimize service delivery and operational efficiency, ensuring patient satisfaction while maintaining cost-effectiveness. By continuously expanding its geographical footprint and diversifying its service portfolio, Medicover is adept at adapting to evolving market demands, thus securing its long-term financial sustainability and reinforcing its commitment to delivering value-driven healthcare solutions.

MCOV B Intrinsic Value
249.85 SEK
Undervaluation 17%
Intrinsic Value
Price kr207.5

See Also

What is Medicover AB's Other Long-Term Assets?
Other Long-Term Assets
45.4m EUR

Based on the financial report for Dec 31, 2025, Medicover AB's Other Long-Term Assets amounts to 45.4m EUR.

What is Medicover AB's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
30%

Over the last year, the Other Long-Term Assets growth was 14%. The average annual Other Long-Term Assets growth rates for Medicover AB have been 42% over the past three years , 30% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett